Loading...
Please wait
ポッドキャスト
読み込み中...
Waves
Explore
Library
Vibes
Podcasts
Audiobooks
ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL - Two Onc Docs | OndaCast
ポッドキャスト
Back to Two Onc Docs
EPISODE
December 16, 2025
ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL
から
Two Onc Docs
•
Sam and Karine
エピソードを再生
ブースト
ショー・ノート
This week’s episode will be focusing on an update of a late-breaking abstract presented at ASH 2025 this past week: the Phase 3 BRUIN-CLL 313 trial looking at Pirtobrutinib vs Bendamustine/Rituximab in 1L Chronic Lymphocytic Leukemia (CLL).
おすすめ
Waves
Explore
Library
Vibes
Podcasts
Audiobooks
